Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Centre Hospitalier Universitaire de Besancon
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Performance status ECOG-WHO 0, 1 or 2
Metastatic colorectal cancer Histologically proved
signed written informed consent
You may not be if
previous treatment (chemotherapy, targeted therapy, surgery) for metastatic disease
history of autoimmune disease
patients under immunotherapy systemic treatment or immunosuppressive drugs or stopped for less than 6 months to the enrollment in this study.
corticoids ≥ 1mg/kg
acute or chronic infectious disease during treatment or stopped for less than six months
other malignancy within the last 5 years, except for adequately treated carcinoma in situ of the cervix or squamous carcinoma of the skin, or adequately controlled limited basal cell skin cancer.
pregnancy, breast-feeding or absence of adequate contraception for fertile patients
patient with any medical or psychiatric condition or disease which would make the patient inappropriate for entry into this study.
patient under guardianship, curator or under the protection of justice.
Clareo Health | Study for Validation of Immunological Biomarkers in Patients With Metastatic Colorectal Cancer
